Do anti-IL-6R blockers have a beneficial effect in the treatment of antibody-mediated rejection resistant to standard therapy after kidney transplantation?
M. Joan Massat, Nicolas Congy‐Jolivet, Anne‐Laure Hebral, Laure Esposito, Olivier Marion, Audrey Delas, Magali Colombat, Stanislas Faguer, Nassim Kamar, Arnaud Del Bello
Topics & Concepts
MedicineTocilizumabRituximabKidney transplantationTransplantationInternal medicineContext (archaeology)AntibodyAbataceptImmunologyGastroenterologyUrologySurgeryDiseasePaleontologyBiologyRenal Transplantation Outcomes and TreatmentsTransplantation: Methods and OutcomesNeurological Complications and Syndromes